Philips is recalling approximately 2,867 Azurion and Allura medical imaging systems configured with a 1 Phase Uninterruptible Power Supply (UPS). These systems have a potential defect where they may shut down unexpectedly or fail to restart if power is lost, which could disrupt critical medical procedures. The recall affects a total of 1,861 Azurion units and 1,006 Allura units distributed worldwide, including across the United States.
If the system loses power and fails to restart or shuts down improperly during a medical procedure, it could lead to delays in diagnosis and treatment, potentially endangering patients. There is a risk that the imaging system will not be available when needed most during clinical interventions.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.